Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People's Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi'an, the People's Republic of China.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone86-29-8819-3188
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Frequently Asked Questions
What is Skystar Bio-Pharmaceutical's stock symbol?
Skystar Bio-Pharmaceutical trades on the OTCMKTS under the ticker symbol "SKBI."
Has Skystar Bio-Pharmaceutical been receiving favorable news coverage?
Media headlines about SKBI stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Skystar Bio-Pharmaceutical earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned media headlines about the healthcare company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
Who are some of Skystar Bio-Pharmaceutical's key competitors?
Some companies that are related to Skystar Bio-Pharmaceutical include Advanced Accelerator Application (AAAP), American Oriental Bioengineering (AOBI), Aralez Pharmaceuticals (ARLZ), ARMO Biosciences (ARMO), Bohai Pharmaceuticals Group (BOPH), Cardiome Pharma (CRME), Concordia International (CXRXD), Concordia International (CXRX), Depomed (DEPO), Egalet (EGLT), Eleven Biotherapeutics (EBIO), Impax Laboratories (IPXL), Juniper Pharmaceuticals (JNP), Oncolytics Biotech (ONCYF) and Orexigen Therapeutics (OREX).
Who are Skystar Bio-Pharmaceutical's key executives?
Skystar Bio-Pharmaceutical's management team includes the folowing people:
- Mr. Weibing Lu, Chairman and Chief Exec. Officer (Age 56)
How do I buy shares of Skystar Bio-Pharmaceutical?
Shares of SKBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Skystar Bio-Pharmaceutical's stock price today?
One share of SKBI stock can currently be purchased for approximately $0.0001.
What is Skystar Bio-Pharmaceutical's official website?
How can I contact Skystar Bio-Pharmaceutical?
Skystar Bio-Pharmaceutical's mailing address is RM 10601 JIEZUO PLAZA NO. 4 FENGHUI ROAD SOUTH, XIAN F4, . The healthcare company can be reached via phone at 86-29-8819-3188 or via email at [email protected]
MarketBeat Community Rating for Skystar Bio-Pharmaceutical (OTCMKTS SKBI)
MarketBeat's community ratings are surveys of what our community members think about Skystar Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe SKBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
